Citation: Ar. Bowers et al., Eye movements and reading with large print and optical magnifiers in macular disease, OPT VIS SCI, 78(5), 2001, pp. 325-334
Citation: Hp. Brunner-la Rocca et al., Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects, J AM COL C, 37(5), 2001, pp. 1221-1227
Citation: Cj. Thomas et al., ANP, BNP, and CNP enhance bradycardic responses to cardiopulmonary chemoreceptor activation in conscious sheep, AM J P-REG, 280(1), 2001, pp. R282-R288
Authors:
Gaspari, TA
Barber, MN
Woods, RL
Dusting, GJ
Citation: Ta. Gaspari et al., Proceedings of the High Blood Pressure Research Council of Australia - Type-C natriuretic peptide prevents development of experimental atherosclerosis in rabbits, CLIN EXP PH, 27(8), 2000, pp. 653-655
Citation: Aj. Afsar et al., A comparison of visual performance between a rigid PMMA and a foldable acrylic intraocular lens, EYE, 13, 1999, pp. 329-335
Citation: Rl. Woods et Mjm. Jones, Atrial, B-type, and C-type natriuretic peptides cause mesenteric vasoconstriction in conscious dogs, AM J P-REG, 45(5), 1999, pp. R1443-R1452
Citation: Cj. Thomas et al., Similar baroreflex bradycardic actions of atrial natriuretic peptide and Band C types of natriuretic peptides in conscious rats, J HYPERTENS, 17(6), 1999, pp. 801-806
Citation: Rl. Woods, Vasoconstrictor actions of atrial natriuretic peptide in the splanchnic circulation of anesthetized dogs, AM J P-REG, 44(6), 1998, pp. R1822-R1832
Citation: Rl. Woods et al., Screening for ophthalmic disease in older subjects using visual acuity andcontrast sensitivity, OPHTHALMOL, 105(12), 1998, pp. 2318-2326